Stock VCBD VITALIBIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Vitalibis, Inc. Share Price

Equities

VCBD

US92849U1051

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 18:31:49 24/05/2024 BST 		5-day change 1st Jan Change
0.0001 USD -.--% Intraday chart for Vitalibis, Inc. -.--% -50.00%
2021 Vitalibis, Inc. Bankruptcy Case Dismissed CI
2021 Motion for Case Dismissal Filed for Vitalibis, Inc. CI
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2018 0.05 4.05 Sales 2019 0.3 23.91 Capitalization 6.78M 535M
Net income 2018 -2M -158M Net income 2019 -6M -473M EV / Sales 2018 949,417,389 x
Net cash position 2018 161K 12.66M Net Debt 2019 1.1M 86.45M EV / Sales 2019 25,986,197 x
P/E ratio 2018
-21.3 x
P/E ratio 2019
-0.95 x
Employees -
Yield 2018 *
-
Yield 2019
-
Free-Float 100%
More Fundamentals * Assessed data

Chart Vitalibis, Inc.

Dynamic Chart

Latest news about Vitalibis, Inc.

Vitalibis, Inc. Bankruptcy Case Dismissed CI
Motion for Case Dismissal Filed for Vitalibis, Inc. CI
Disclosure Statement Conditionally Approved for Vitalibis, Inc. CI
Reorganization Plan and Disclosure Statement Filed by Vitalibis, Inc. CI
Vitalibis, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Vitalibis, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
Vitalibis, Inc. Filed for Bankruptcy CI
Vitalibis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
Vitalibis, Inc. Alliance with Bruce Lee Beverage by Offering Actual Being™ Focus Adaptogen + Superfood Herbal Supplement CI
Vitalibis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Vitalibis, Inc. Auditor Raises 'Going Concern' Doubt CI
Vitalibis, Inc. Launches CBD+ Skincare Product Line CI
Vitalibis and OakLeaf Wellness + Health Announce National Alliance to Distribute Full-Spectrum CBD Wellness Products CI
Vitalibis, Inc. and Stylevate Completes Technology Integration Using Proprietary Peer-to-Peer Engagement SaaS Platform In Fashion Industry CI
Vitalibis, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019 CI
More news

Press releases Vitalibis, Inc.

VITALIBIS, INC. : Other Events (form 8-K) AQ
VITALIBIS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) AQ
VITALIBIS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) AQ
VITALIBIS, INC. : Bankruptcy or Receivership (form 8-K) AQ
VITALIBIS, INC. : Other Events (form 8-K) AQ
More press releases

Quotes and Performance

6 months-50.00%
Current year-50.00%
More quotes

Highs and lows

1 month
0.00
Extreme 0.0001
0.00
Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.01
3 years
0.00
Extreme 0
0.01
5 years
0.00
Extreme 0
0.58
10 years
0.00
Extreme 0
4.91
More quotes

Managers and Directors - Vitalibis, Inc.

Managers TitleAgeSince
Steven Raack FOU
 Founder 52 10/04/14
Thomas Raack DFI
 Director of Finance/CFO 53 23/10/17
Members of the board TitleAgeSince
Thomas Raack DFI
 Director of Finance/CFO 53 23/10/17
Steven Raack FOU
 Founder 52 10/04/14
More insiders

Company Profile

Vitalibis, Inc. is a socially conscious brand focused on people, products and the planet. The Company is a technology-based formulator of premium, full spectrum Phyto cannabinoid rich hemp products with naturally occurring cannabidiol, along with safe personal care and nutritional products. The Company’s Ambassador program combines the elements of social selling, ecommerce and affiliate marketing into one program empowering its people and social mission driven ecosystem.
Sector
Pharmaceuticals
More about the company

Sector Other Pharmaceuticals

1st Jan change Capi.
VITALIBIS, INC. Stock Vitalibis, Inc.
-50.00% 34.59K
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+50.70% 791B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.96% 630B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.15% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.77% 328B
ABBVIE INC. Stock AbbVie Inc.
+8.79% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.02% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+1.27% 225B
NOVARTIS AG Stock Novartis AG
+11.95% 218B
AMGEN INC. Stock Amgen Inc.
+3.68% 160B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. VCBD Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW